# Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis

> **NCT01357980** · PHASE2 · COMPLETED · sponsor: **Ipsen** · enrollment: 47 (actual)

## Conditions studied

- Detrusor Muscle Hyperactivity

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01357980
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357980, "Neurogenic Detrusor Overactivity Following Spinal Cord Injury or Multiple Sclerosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01357980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*